Wen‐Fei Li

5.7k total citations · 1 hit paper
56 papers, 2.0k citations indexed

About

Wen‐Fei Li is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Wen‐Fei Li has authored 56 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Otorhinolaryngology, 23 papers in Surgery and 22 papers in Oncology. Recurrent topics in Wen‐Fei Li's work include Head and Neck Cancer Studies (35 papers), Head and Neck Surgical Oncology (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Wen‐Fei Li is often cited by papers focused on Head and Neck Cancer Studies (35 papers), Head and Neck Surgical Oncology (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Wen‐Fei Li collaborates with scholars based in China, United States and Singapore. Wen‐Fei Li's co-authors include Jun Ma, Ying Sun, Lei Chen, Aihua Lin, Lizhi Liu, Yan‐Ping Mao, Ling‐Long Tang, Yuanyuan Chen, Mengzhong Liu and Wei Luo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Wen‐Fei Li

54 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?

2010 530 citations Wen‐Fei Li, Lei Chen et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers

Countries citing papers authored by Wen‐Fei Li

Since Specialization

Citations

This map shows the geographic impact of Wen‐Fei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Fei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Fei Li more than expected).

Fields of papers citing papers by Wen‐Fei Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Fei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Fei Li. The network helps show where Wen‐Fei Li may publish in the future.

Co-authorship network of co-authors of Wen‐Fei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Fei Li. A scholar is included among the top collaborators of Wen‐Fei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Fei Li. Wen‐Fei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A radiogenomic clinical decision support system to inform individualized treatment in advanced nasopharyngeal carcinoma 2024 ·iScience ·Xueliang Fang, (unknown), Wei Jiang, (unknown), Lei Yuan, Siqi Tang, Qingjie Li, Lizhi Liu, Li Tian, Ying‐Qin Li, Yu‐Pei Chen, Li Lin, Rui Guo, Wen‐Fei Li, Jie Tian, Na Liu, Di Dong, Jun Ma, Ling‐Long Tang	1
2	Patterns and Prognosis of Local Recurrence of Nasopharyngeal Carcinoma after Intensity-modulated Radiotherapy 2023 ·Journal of Cancer ·(unknown), (unknown), Yu‐Pei Chen, Rui Guo, Ling‐Long Tang, Ying Sun, Jun Ma, Wen‐Fei Li	2
3	A tumor microenvironment-associated circRNA predictor for tumor relapse and chemotherapy vulnerability in nasopharyngeal carcinoma 2023 ·iScience ·Ye‐Lin Liang, (unknown), Cong Ding, (unknown), Qian Li, (unknown), Qing‐Mei He, Ling‐Long Tang, Yan‐Ping Mao, Lei Chen, Wen‐Fei Li, Guan‐Qun Zhou, Na Liu, Wei Jiang, (unknown), Ying‐Qin Li	4
4	Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study 2022 ·Radiation Oncology ·(unknown), Kai‐Bin Yang, Ying Huang, (unknown), (unknown), Lei Chen, Wen‐Fei Li, Xiaodan Huang, Li Lin, Yu‐Pei Chen, Yan‐Ping Mao, Ling‐Long Tang, Jun Ma	5
5	Long-Term Evaluation and Normal Tissue Complication Probability (NTCP) Models for Predicting Radiation-Induced Optic Neuropathy after Intensity-Modulated Radiation Therapy (IMRT) for Nasopharyngeal Carcinoma: A Large Retrospective Study in China 2022 ·Journal of Oncology ·(unknown), Wen‐Fei Li, Kai‐Bin Yang, Lei Chen, (unknown), Fo‐Ping Chen, Xiaodan Huang, Li Lin, Xiaomin Zhang, (unknown), Yu‐Pei Chen, Ling‐Long Tang, Yan‐Ping Mao, Jun Ma	10
6	The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinoma 2022 ·Cancer Medicine ·Xiaomin Li, Xiaomin Zhang, Junyan Li, Ning Jiang, Lei Chen, Ling‐Long Tang, Yan‐Ping Mao, Wen‐Fei Li, Guan‐Qun Zhou, Ying‐Qin Li, Na Liu, Yuan Zhang, Jun Ma	8
7	Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial 2021 ·Radiotherapy and Oncology ·Siqi Tang, Lei Chen, Wen‐Fei Li, Anthony T.�C. Chan, Shao Hui Huang, Melvin L.K. Chua, Brian O’Sullivan, Anne W.M. Lee, Nancy Y. Lee, Yuan Zhang, Yu‐Pei Chen, Cheng Xu, Ying Sun, Ling‐Long Tang, Jun Ma	17
8	Combining tumor response and personalized risk assessment: Potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era 2020 ·Radiotherapy and Oncology ·Wei‐Jie Luo, (unknown), Shaobo Liang, Lei Chen, Guan‐Qun Zhou, Hao Peng, Wen‐Fei Li, Xu Liu, Ying Sun, Aihua Lin, Jun Ma, Yan‐Ping Mao	13
9	Association between outcome disparities and pragmatic features related to clinical trial and real-world settings in nasopharyngeal carcinoma: A population-based retrospective cohort study, 2006–2016 2020 ·Radiotherapy and Oncology ·Cheng Xu, Yuan Zhang, Lei Chen, Wen‐Fei Li, Siqi Tang, Ling‐Long Tang, Ying Guo, Qing Liu, Aihua Lin, Ying Sun, Jun Ma	2
10	The evolution of the nasopharyngeal carcinoma staging system over a 10-year period: implications for future revisions 2020 ·Chinese Medical Journal ·Siqi Tang, Yan‐Ping Mao, Cheng Xu, Rui Guo, Wen‐Fei Li, Ling‐Long Tang, Ying Sun, Jun Ma	9
11	Patterns of EBV-positive cervical lymph node involvement in head and neck cancer and implications for the management of nasopharyngeal carcinoma T0 classification 2019 ·Oral Oncology ·Wei‐Jie Luo, Yanfen Feng, Rui Guo, Ling‐Long Tang, Lei Chen, Guan‐Qun Zhou, Wen‐Fei Li, Xu Liu, Ying Sun, Aihua Lin, Jun Ma, Yan‐Ping Mao	16
12	Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis 2018 ·BMC Cancer ·Hao Peng, Ling‐Long Tang, Xu Liu, Lei Chen, Wen‐Fei Li, Yan‐Ping Mao, Yuan Zhang, Lizhi Liu, Li Tian, Ying Guo, Ying Sun, Jun Ma	19
13	Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy 2017 ·Chinese Journal of Cancer ·Hao Peng, Lei Chen, Ling‐Long Tang, Wen‐Fei Li, Yan‐Ping Mao, Rui Guo, Yuan Zhang, Lizhi Liu, Li Tian, Xu Zhang, Xiaoping Lin, Ying Guo, Ying Sun, Jun Ma	19
14	Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation Therapy 2016 ·Scientific Reports ·Hao Peng, Rui Guo, Lei Chen, Yuan Zhang, Wen‐Fei Li, Yan‐Ping Mao, Ying Sun, Fan Zhang, Lizhi Liu, Aihua Lin, Jun Ma	58
15	Exploration and Validation of C-Reactive Protein/Albumin Ratio as a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma 2016 ·Journal of Cancer ·Yuan Zhang, Guan‐Qun Zhou, (unknown), Lei Chen, Wen‐Fei Li, Ling‐Long Tang, Qing Liu, Ying Sun, Jun Ma	49
16	Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma? 2012 ·Radiotherapy and Oncology ·Rui Guo, Ying Sun, (unknown), Wenjing Yin, Wen‐Fei Li, Yuanyuan Chen, Yan‐Ping Mao, Lizhi Liu, Li Li, Aihua Lin, Jun Ma	110
17	Baseline Serum Lactate Dehydrogenase Levels for Patients Treated With Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: A Predictor of Poor Prognosis and Subsequent Liver Metastasis 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Guan‐Qun Zhou, Ling‐Long Tang, Yan‐Ping Mao, Lei Chen, Wen‐Fei Li, Ying Sun, Lizhi Liu, Li Li, Aihua Lin, Jun Ma	93
18	Association of FK506 binding protein 5 (FKBP5) gene rs4713916 polymorphism with mood disorders: a meta-analysis 2011 ·Acta Neuropsychiatrica ·Xiao-Liang Feng, Fang Wang, Yanfeng Zou, Wen‐Fei Li, Yanghua Tian, Faming Pan, Fen Huang	5
19	Association of DRD2 gene polymorphisms with mood disorders: A meta-analysis 2010 ·Journal of Affective Disorders ·Yanfeng Zou, (unknown), Xiao-Liang Feng, Wen‐Fei Li, Yanghua Tian, Jin‐Hui Tao, Faming Pan, Fen Huang	38
20	Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders 2010 ·Neuroscience Letters ·Yanfeng Zou, Fang Wang, Xiao-Liang Feng, Wen‐Fei Li, Jin‐Hui Tao, Faming Pan, Fen Huang, Hong Su	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact